Position in ABCL
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$7,778,792
+$2,506,697 QoQ
Shares Held
990,929
-34.4% QoQ
Ownership
0.323%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#18
of 150 holders
Holding Since
Jun 2021
21 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABCL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026RENAISSANCE TECHNOLOGIES LLC holds $3,952,606,887 across 312 Biotechnology names. ABCL ranks #64 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | EXEL |
Exelixis, Inc.
|
13,427,993 | $730,617,099 | |
| 2 | CORT |
Corcept Therapeutics Inc
|
5,261,628 | $457,498,554 | |
| 3 | INCY |
Incyte Corp
|
3,512,132 | $398,135,283 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
320,008 | $158,957,573 | |
| 5 | JAZZ |
Jazz Pharmaceuticals plc
|
562,073 | $135,442,730 | |
| 6 | RPRX |
Royalty Pharma plc
|
1,935,800 | $108,540,306 | |
| 7 | TVTX |
Travere Therapeutics, Inc.
|
1,833,079 | $104,137,217 | |
| 8 | GMAB |
Genmab A/S
|
3,517,850 | $96,635,339 |
All Filings in ABCL
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $7,778,792 | 990,929 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $5,272,095 | 1,510,629 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $8,171,163 | 2,389,229 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $16,904,466 | 3,360,729 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $11,344,481 | 3,307,429 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $6,453,684 | 2,894,029 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $7,286,596 | 2,486,893 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $7,661,427 | 2,946,703 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $5,116,664 | 1,728,603 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $6,747,901 | 1,489,603 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $8,333,762 | 1,459,503 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $7,783,443 | 1,692,053 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $16,386,455 | 2,536,603 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $21,198,732 | 2,811,503 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $21,499,942 | 2,122,403 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $29,480,141 | 2,980,803 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $42,986,626 | 4,036,303 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $25,521,629 | 2,617,603 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $7,710,602 | 539,203 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $1,689,372 | 84,300 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $8,870,400 | 403,200 | Shares | Sole | 2021-08-13 | |
| No filing history on record for this holder in this stock. | ||||||